1.
J Drugs Dermatol
; 20(8): 914-916, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34397203
RESUMO
Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects.